生物催化
生化工程
生物过程
合成生物学
蛋白质工程
范围(计算机科学)
代谢工程
工业生物技术
定向进化
定向分子进化
生物过程工程
生物技术
化学
纳米技术
计算机科学
工程类
酶
计算生物学
材料科学
生物
生物化学
催化作用
离子液体
基因
突变体
程序设计语言
化学工程
作者
Roger A. Sheldon,Dean Brady
标识
DOI:10.1021/acssuschemeng.1c01742
摘要
In this Perspective we show how an expansion of the scope and impact of biocatalysis in industrial organic synthesis is enabled by streamlining the underpinning biocatalyst and bioprocess engineering. We begin by discussing how the underlying need for waste reduction and high (enantio)selectivities fostered the introduction of biocatalysis as a sustainable technology for the industrial synthesis of active pharmaceutical ingredients (APIs). We continue by showing how advances in molecular biology, in particular gene sequencing and protein engineering, enabled the development of more and better enzymes, thereby broadening the industrial scope of biocatalysis. Further process improvements are provided through protein engineering for enzyme immobilization and integration of enzyme production with in vivo immobilization. Finally, the use of immobilized enzymes in continuous operation (biocatalysis in flow) facilitates the sequential integration of multi-step reactions into enzymatic or chemo-enzymatic cascade processes, thus enabling the complete, cost-effective, and environmentally attractive production of APIs.
科研通智能强力驱动
Strongly Powered by AbleSci AI